George Faurot

George Faurot serves as the Chief Operating Officer at InClin Inc., a role held since 2018, following positions as SVP Clinical Operations and various leadership roles in clinical research and project management. With extensive therapeutic area experience spanning Phase 1 to 3 clinical trials, George has specialized in indications ranging from antibiotics to oncology and rare diseases. Previous roles include Senior Clinical Research Associate and Clinical Program Manager at Oculex Pharmaceuticals, along with clinical research leadership at Matrix Pharmaceutical and Syntex Development Research. George holds a BS in Toxicology from the University of California, Davis, and has significant expertise in clinical quality assurance and health authority inspections across multiple international jurisdictions.